Immunomodulatory effects of intravenous BIS-1 F(ab')2 administration in renal cell cancer patients (Q42590716)

From Wikidata

Jump to navigation Jump to search

scientific article published on September 1, 1995

edit

Language	Label	Description	Also known as
English	Immunomodulatory effects of intravenous BIS-1 F(ab')2 administration in renal cell cancer patients	scientific article published on September 1, 1995

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PMC publication ID

2033869

retrieved

3 November 2017

title

Immunomodulatory effects of intravenous BIS-1 F(ab')2 administration in renal cell cancer patients (English)

1 reference

stated in

Europe PubMed Central

PMC publication ID

2033869

retrieved

3 November 2017

main subject

active immunotherapy

1 reference

stated in

Europe PubMed Central

PubMed publication ID

7669598

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7669598

retrieved

2 August 2024

author

Dirk T. Sleijfer

series ordinal

5

object named as

D. T. Sleijfer

1 reference

stated in

Europe PubMed Central

PubMed publication ID

7669598

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7669598

retrieved

2 August 2024

author name string

R. A. Janssen

series ordinal

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

7669598

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7669598

retrieved

2 August 2024

B. J. Kroesen

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

7669598

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7669598

retrieved

2 August 2024

J. Buter

series ordinal

3

1 reference

stated in

Europe PubMed Central

PubMed publication ID

7669598

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7669598

retrieved

2 August 2024

G. Mesander

series ordinal

4

1 reference

stated in

Europe PubMed Central

PubMed publication ID

7669598

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7669598

retrieved

2 August 2024

T. H. The

series ordinal

6

1 reference

stated in

Europe PubMed Central

PubMed publication ID

7669598

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7669598

retrieved

2 August 2024

N. H. Mulder

series ordinal

7

1 reference

stated in

Europe PubMed Central

PubMed publication ID

7669598

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7669598

retrieved

2 August 2024

L. de Leij

series ordinal

8

1 reference

stated in

Europe PubMed Central

PubMed publication ID

7669598

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7669598

retrieved

2 August 2024

language of work or name

English

0 references

publication date

1 September 1995

1 reference

stated in

Europe PubMed Central

PMC publication ID

2033869

retrieved

3 November 2017

full work available at URL

https://europepmc.org/articles/pmc2033869?pdf=render

file format

Portable Document Format

online access status

open access

1 reference

stated in

Europe PubMed Central

PubMed publication ID

7669598

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7669598

retrieved

2 August 2024

https://europepmc.org/articles/PMC2033869

file format

HTML

online access status

open access

content deliverer

Europe PubMed Central

1 reference

stated in

Europe PubMed Central

PubMed publication ID

7669598

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7669598

retrieved

2 August 2024

https://europepmc.org/articles/PMC2033869?pdf=render

file format

Portable Document Format

online access status

open access

content deliverer

Europe PubMed Central

1 reference

stated in

Europe PubMed Central

PubMed publication ID

7669598

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7669598

retrieved

2 August 2024

http://www.nature.com/articles/bjc1995414.pdf

file format

Portable Document Format

1 reference

stated in

Crossref

DOI

10.1038/BJC.1995.414

reference URL

https://api.crossref.org/works/10.1038/BJC.1995.414

retrieved

2 August 2024

http://www.nature.com/articles/bjc1995414

1 reference

stated in

Crossref

DOI

10.1038/BJC.1995.414

reference URL

https://api.crossref.org/works/10.1038/BJC.1995.414

retrieved

2 August 2024

published in

British Journal of Cancer

1 reference

stated in

Europe PubMed Central

PMC publication ID

2033869

retrieved

3 November 2017

volume

72

1 reference

stated in

Europe PubMed Central

PMC publication ID

2033869

retrieved

3 November 2017

issue

3

1 reference

stated in

Europe PubMed Central

PMC publication ID

2033869

retrieved

3 November 2017

page(s)

795-799

1 reference

stated in

Europe PubMed Central

PMC publication ID

2033869

retrieved

3 November 2017

cites work

Phase I study of intravenously applied bispecific antibody in renal cell cancer patients receiving subcutaneous interleukin 2.

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033869

retrieved

28 May 2018

SCLC-cluster-2 antibodies detect the pancarcinoma/epithelial glycoprotein EGP-2.

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033869

retrieved

28 May 2018

Influence of schedule of interleukin 2 administration on therapy with interleukin 2 and lymphokine activated killer cells

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033869

retrieved

28 May 2018

Phase II study of subcutaneous interleukin-2 in unselected patients with advanced renal cell cancer on an outpatient basis

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033869

retrieved

28 May 2018

HLA-Dr-expressing CD8bright cells are only temporarily present in the circulation during subcutaneous recombinant interleukin-2 therapy in renal cell carcinoma patients

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/7669598

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

OKT3 F(ab')2 fragments--retention of the immunosuppressive properties of whole antibody with marked reduction in T cell activation and lymphokine release

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/7669598

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

T cell receptor/CD3 complex internalization following activation of a cytolytic T cell clone: evidence for a protein kinase C-independent staurosporine-sensitive step

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/7669598

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cytolytic potential of peripheral blood T-lymphocytes following adoptive immunotherapy with lymphokine-activated killer cells and low-dose interleukin 2

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/7669598

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cytokine release in an ovarian carcinoma patient following intravenous administration of bispecific antibody OC/TR F(ab')2

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/7669598

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The immunobiological effects of interleukin-2 in vivo

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/7669598

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Poor induction of interleukin-2 receptor expression on CD8bright+ cells in whole blood cell cultures with CD3 mAb. Implications for immunotherapy with CD3 mAb

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/7669598

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

DOI

10.1038/BJC.1995.414

1 reference

stated in

Europe PubMed Central

PMC publication ID

2033869

retrieved

3 November 2017

Dimensions Publication ID

1042603060

0 references

PMC publication ID

2033869

1 reference

stated in

Europe PubMed Central

PMC publication ID

2033869

retrieved

3 November 2017

PubMed publication ID

7669598

1 reference

stated in

Europe PubMed Central

PMC publication ID

2033869

retrieved

3 November 2017

ResearchGate publication ID

15528756

0 references

 

Sitelinks

Wikipedia(0 entries)

edit

Wikibooks(0 entries)

edit

Wikinews(0 entries)

edit

Wikiquote(0 entries)

edit

Wikisource(0 entries)

edit

Wikiversity(0 entries)

edit

Wikivoyage(0 entries)

edit

Wiktionary(0 entries)

edit

Multilingual sites(0 entries)

edit

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42590716&oldid=2260546966"